Author(s): James Chih-Hsin Yang, M.D., Ph.D.1; Shun Lu, M.D., Ph.D.2; Hidetoshi Hayashi, M.D., Ph.D.3; Enriqueta Felip, M.D., Ph.D.4; Alexander I. Spira, M.D., Ph.D.5; Nicolas Girard, M.D., Ph.D.6,7; Yu Jung Kim, M.D., Ph.D.8; Se-Hoon Lee, M.D., Ph.D.9; Yurii Ostapenko, M.D., Ph.D.10; Pongwut Danchaivijitr, M.D.11; Baogang Liu, M.D.12; Adlinda Alip, M.D.13; Ernesto Korbenfeld, M.D.14; Josiane Mourão Dias, M.D.15; Benjamin Besse, M.D., Ph.D.16; Antonio Passaro, M.D., Ph.D.17; Ki-Hyeong Lee, M.D.18; Hailin Xiong, M.D.19; Soon-Hin How, M.D.20; Ying Cheng, M.D.21; Gee-Chen Chang, M.D., Ph.D.22; Hiroshige Yoshioka, M.D., Ph.D.23; Michael Thomas, M.D.24,25,26; Danny Nguyen, M.D.27; Sai-Hong Ignatius Ou, M.D., Ph.D.28; Sanjay Mukhedkar, M.D.29; Kumar Prabhash, M.D., D.M.30; Manolo D’Arcangelo, M.D.31; Jorge Alatorre-Alexander, M.D.32; Juan Carlos Vázquez Limón, M.D.33; Sara Alves, M.D.34; Daniil Stroyakovskiy, M.D.35; Marina Peregudova, M.D., Ph.D.36; Mehmet Ali Nahit Şendur, M.D., Ph.D.37; Ozan Yazici, M.D.38; Raffaele Califano, M.D.39; Vanesa Gutiérrez Calderón, M.D.40; Filippo de Marinis, M.D.17; Sang-We Kim, M.D., Ph.D.41; Shirish M. Gadgeel, M.D., Ph.D.42; Scott Owen, M.D.43; John Xie, Ph.D.44; Tao Sun, Ph.D.44; Jaydeep Mehta, Ph.D.45; Raja Venkatasubramanian, Ph.D.46; Mariah Ennis, M.S.45; Elizabeth Fennema, M.A.47; Mahesh Daksh, Ph.D.44; Amy Roshak, B.S.45; Julie Man, M.S.44; Roland E. Knoblauch, M.D., Ph.D.45; Joshua M. Bauml, M.D.45; Mahadi Baig, M.D.44; Sujay Shah, M.D.45; Seema Sethi, D.O.45; Byoung Chul Cho, M.D., Ph.D.48; the MARIPOSA Investigators*;
Author Affiliations
1National Taiwan University Cancer Center, National Taiwan University Hospital, Taipei, Taiwan; 2Department of Medical Oncology, Shanghai Chest Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China; 3Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan; 4Medical Oncology Service, Vall d’Hebron Institute of Oncology, Vall d’Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Barcelona; 5Virginia Cancer Specialists, Fairfax; 6Institut Curie, Paris; 7Paris-Saclay University, Université de Versailles Saint-Quentin-en-Yvelines, Versailles, France; 8Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, South Korea; 9Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea; 10National Cancer Institute, Kyiv, Ukraine; 11Division of Medical Oncology, Department of Medicine, Siriraj Hospital Faculty of Medicine, Mahidol University Bangkok Noi Campus, Bangkok, Thailand; 12Harbin Medical University Cancer Hospital, Harbin, China; 13Clinical Oncology Department, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia; 14British Hospital of Buenos Aires, Central British Hospital, Buenos Aires; 15Department of Medical Oncology, Barretos Cancer Hospital, São Paulo; 16Paris-Saclay University, Gustave Roussy, Villejuif, France; 17Division of Thoracic Oncology, European Institute of Oncology IRCCS, Milan; 18Medical Department, Chungbuk National University Hospital, Cheongju, South Korea; 19Department of Medical Oncology, Huizhou Municipal Central Hospital of Guangdong Province, Huizhou, China; 20Department of Internal Medicine, Division of Respiratory Medicine, International Islamic University Malaysia Medical Specialist Center, Pahang, Malaysia; 21Jilin Cancer Hospital, Changchun, China; 22School of Medicine and Institute of Medicine, Chung Shan Medical University and Division of Pulmonary Medicine, Department of Internal Medicine, Chung Shan Medical University Hospital, Taichung, Taiwan; 23Department of Thoracic Oncology, Kansai Medical University Hospital, Hirakata, Japan; 24Department of Thoracic Oncology, Thoraxklinik, Heidelberg University Hospital, Heidelberg, Germany; 25National Center for Tumor Diseases Heidelberg, a partnership between the German Cancer Research Center and Heidelberg University Hospital, Heidelberg, Germany; 26Translational Lung Research Center Heidelberg, German Center for Lung Research, Heidelberg, Germany; 27City of Hope National Medical Center, Duarte, CA; 28University of California, Irvine School of Medicine, Orange; 29St. John of God Murdoch Hospital, Murdoch, WA, Australia; 30Department of Medical Oncology, Division of Adult Solid Tumor Oncology, Tata Memorial Hospital, Mumbai, India; 31Local Health Unit Authority of Romagna, Ravenna Hospital and Department of Onco-Hematology, Santa Maria delle Croci Hospital of Ravenna, Emilia-Romagna, Italy; 32Health Pharma Professional Research, Mexico City; 33Oncología Médica, Antiguo Hospital Civil de Guadalajara “Fray Antonio Alcalde” and Universidad de Guadalajara, Guadalajara, Mexico; 34Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal; 35Moscow City Oncology Hospital No. 62, Moscow; 36Medical Center in Kolomenskoe, Moscow; 37Department of Medical Oncology, Ankara Bilkent City Hospital and Ankara Yıldırım Beyazıt University, Ankara, Turkey; 38Department of Medical Oncology, Gazi University Faculty of Medicine, Ankara, Turkey; 39Department of Medical Oncology, Christie NHS Foundation Trust and Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom; 40Medical Oncology Department, Hospital Regional Universitario de Málaga, Málaga, Spain; 41Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea; 42Division of Hematology-Oncology, Henry Ford Cancer Institute, Henry Ford Health, Detroit; 43Department of Medical Oncology, McGill University Health Centre, Montreal; 44Johnson & Johnson, Raritan, NJ; 45Johnson & Johnson, Spring House, PA; 46Johnson & Johnson, Titusville, NJ; 47Johnson & Johnson, San Diego, CA; 48Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea